INmune Bio, Inc. (INMB) Revenue History
INmune Bio, Inc. (INMB) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2018-12-31 | N/A |
| 2019-12-31 | N/A |
| 2020-12-31 | $11.00K |
| 2021-12-31 | $181.00K |
| 2022-12-31 | $374.00K |
| 2023-12-31 | $155.00K |
| 2024-12-31 | $14.00K |
| 2025-12-31 | $50.00K |
How INMB compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| PLSE | Pulse Biosciences Inc | $350.00K |
| BNTC | Benitec Biopharma Inc. | $75.00K |
| INO | Inovio Pharmaceuticals Inc. | $65.34K |
| ALT | Altimmune Inc. | $41.00K |
| ALLO | Allogene Therapeutics Inc. | $22.00K |
These are five companies in the same sector as INMB with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get INmune Bio, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("INMB", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | INMB | $2.08 | +1.96% | 0.21M |
| 3 | ||||
| 4 | ||||
| 5 |